EPIRUS Biopharmaceuticals Inc (EPRSQ)
0.00
USD |
OTCM |
May 03, 16:00
EPIRUS Biopharmaceuticals Shareholders Equity (Quarterly): 26.17M for March 31, 2016
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2016 | 26.17M |
December 31, 2015 | 36.37M |
September 30, 2015 | 50.70M |
June 30, 2015 | 59.11M |
March 31, 2015 | 73.62M |
December 31, 2014 | 32.40M |
September 30, 2014 | 42.40M |
June 30, 2014 | 14.31M |
March 31, 2014 | 10.66M |
December 31, 2013 | -39.38M |
September 30, 2013 | 15.50M |
June 30, 2013 | 16.59M |
March 31, 2013 | 23.50M |
December 31, 2012 | 31.03M |
September 30, 2012 | 38.94M |
June 30, 2012 | 39.02M |
March 31, 2012 | 45.75M |
December 31, 2011 | 43.91M |
September 30, 2011 | 53.95M |
June 30, 2011 | 62.54M |
March 31, 2011 | 68.56M |
December 31, 2010 | 63.00M |
Date | Value |
---|---|
September 30, 2010 | 74.40M |
June 30, 2010 | 85.28M |
March 31, 2010 | 93.26M |
December 31, 2009 | 52.91M |
September 30, 2009 | 11.03M |
June 30, 2009 | 16.86M |
March 31, 2009 | 7.645M |
December 31, 2008 | 15.88M |
September 30, 2008 | 30.10M |
June 30, 2008 | 44.01M |
March 31, 2008 | 60.14M |
December 31, 2007 | 75.24M |
September 30, 2007 | 54.51M |
June 30, 2007 | 68.50M |
March 31, 2007 | 76.92M |
December 31, 2006 | 87.05M |
September 30, 2006 | 94.98M |
June 30, 2006 | 101.38M |
March 31, 2006 | 108.22M |
December 31, 2005 | 68.35M |
September 30, 2005 | -93.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 61.34M |
Total Liabilities (Quarterly) | 35.18M |